Published in Nat Commun on January 01, 2013
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res (2013) 2.67
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell (2015) 1.52
Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice. Cell Metab (2015) 1.51
The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. Am J Respir Crit Care Med (2015) 1.45
Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol (2015) 1.44
Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One (2017) 1.40
The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med (2015) 1.33
A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J (2015) 1.18
Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients (2015) 1.18
The SCFA Receptor GPR43 and Energy Metabolism. Front Endocrinol (Lausanne) (2014) 1.09
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circ Res (2015) 1.08
Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS One (2014) 1.03
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) (2014) 1.03
Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children. Sci Rep (2014) 1.00
The role of microbial amino acid metabolism in host metabolism. Nutrients (2015) 0.99
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes (2016) 0.99
Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil (2016) 0.97
The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond) (2015) 0.97
An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion. Mol Endocrinol (2015) 0.96
Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. J Am Soc Nephrol (2015) 0.95
The interplay between the gut microbiota and the immune system. Gut Microbes (2014) 0.93
A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun (2016) 0.92
Gut Microbiota and Metabolic Disorders. Diabetes Metab J (2015) 0.91
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology (2016) 0.91
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm (2014) 0.91
Regulation of Energy Homeostasis via GPR120. Front Endocrinol (Lausanne) (2014) 0.90
GPR43 Potentiates β-Cell Function in Obesity. Diabetes (2015) 0.89
Treatment of type 2 diabetes by free Fatty Acid receptor agonists. Front Endocrinol (Lausanne) (2014) 0.89
Regulation of Energy Homeostasis by GPR41. Front Endocrinol (Lausanne) (2014) 0.89
The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome. PLoS One (2014) 0.89
Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front Pharmacol (2014) 0.88
Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol (2016) 0.88
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients (2016) 0.87
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol (2014) 0.86
Short-chain fatty acid sensing in rat duodenum. J Physiol (2015) 0.86
Daily Eating Patterns and Their Impact on Health and Disease. Trends Endocrinol Metab (2015) 0.86
A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem (2014) 0.85
SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets? Trends Endocrinol Metab (2016) 0.84
The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis (2016) 0.84
Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J (2015) 0.84
Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mamm Genome (2014) 0.84
Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs. Br J Pharmacol (2013) 0.83
Gut microbiota in hypertension. Curr Opin Nephrol Hypertens (2015) 0.82
Disparate Metabolic Responses in Mice Fed a High-Fat Diet Supplemented with Maize-Derived Non-Digestible Feruloylated Oligo- and Polysaccharides Are Linked to Changes in the Gut Microbiota. PLoS One (2016) 0.82
Metabolic tinkering by the gut microbiome: Implications for brain development and function. Gut Microbes (2014) 0.82
Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes. Adipocyte (2014) 0.82
Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol (2013) 0.81
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature. J Obes (2016) 0.81
Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43. PLoS One (2014) 0.81
Should we build "obese" or "lean" anaerobic digesters? PLoS One (2014) 0.81
The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes. Sci Rep (2015) 0.81
Obesity, Asthma, and the Microbiome. Physiology (Bethesda) (2016) 0.81
Beneficial effects of Korean traditional diets in hypertensive and type 2 diabetic patients. J Med Food (2014) 0.81
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care (2015) 0.80
The enteric microbiome in hepatobiliary health and disease. Liver Int (2015) 0.80
Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-fat Diet in the Pre-Obesity State. Sci Rep (2016) 0.80
Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. Physiol Rep (2015) 0.80
The gut microbiome in cardio-metabolic health. Genome Med (2015) 0.80
AMPKα, C/EBPβ, CPT1β, GPR43, PPARγ, and SCD Gene Expression in Single- and Co-cultured Bovine Satellite Cells and Intramuscular Preadipocytes Treated with Palmitic, Stearic, Oleic, and Linoleic Acid. Asian-Australas J Anim Sci (2015) 0.80
Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology. J Nutr Biochem (2015) 0.80
The Gut-Brain Axis: The Missing Link in Depression. Clin Psychopharmacol Neurosci (2015) 0.80
Assessment of tick antioxidant responses to exogenous oxidative stressors and insight into the role of catalase in the reproductive fitness of the Gulf Coast tick, Amblyomma maculatum. Insect Mol Biol (2016) 0.80
Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review. Front Microbiol (2017) 0.79
Nutritional Signaling via Free Fatty Acid Receptors. Int J Mol Sci (2016) 0.79
Deletion of the Neurotrophic Factor neudesin Prevents Diet-induced Obesity by Increased Sympathetic Activity. Sci Rep (2015) 0.79
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative? Front Immunol (2016) 0.79
Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep (2015) 0.79
Perspectives on the therapeutic potential of short-chain fatty acid receptors. BMB Rep (2014) 0.79
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol (2015) 0.79
Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota. Sci Rep (2016) 0.78
Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling. Microorganisms (2015) 0.78
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther (2016) 0.78
Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis. Curr Diab Rep (2015) 0.78
The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Int J Mol Sci (2016) 0.78
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol (2014) 0.78
Gut Microbiota in Cardiovascular Health and Disease. Circ Res (2017) 0.77
Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice. Sci Rep (2016) 0.77
The Expression of Adipogenic Genes in Adipose Tissues of Feedlot Steers Fed Supplementary Palm Oil or Soybean Oil. Asian-Australas J Anim Sci (2016) 0.77
Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models. PLoS One (2015) 0.77
Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol (2016) 0.77
New Insights into the High-Density Lipoprotein Dilemma. Trends Endocrinol Metab (2015) 0.76
Fatty acids from diet and microbiota regulate energy metabolism. F1000Res (2015) 0.76
High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS One (2016) 0.76
Modulation of voltage-gated Ca2+ channels by G protein-coupled receptors in celiac-mesenteric ganglion neurons of septic rats. PLoS One (2015) 0.76
Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. Br J Clin Pharmacol (2016) 0.76
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep (2016) 0.76
Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice. J Clin Biochem Nutr (2015) 0.76
Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci Rep (2016) 0.76
Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle. Front Genet (2017) 0.75
Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. Adipocyte (2016) 0.75
Expanding Duplication of Free Fatty Acid Receptor-2 (GPR43) Genes in the Chicken Genome. Genome Biol Evol (2015) 0.75
β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue. JCI Insight (2017) 0.75
The Salivary IgA Flow Rate Is Increased by High Concentrations of Short-Chain Fatty Acids in the Cecum of Rats Ingesting Fructooligosaccharides. Nutrients (2016) 0.75
Expanding role of gut microbiota in lipid metabolism. Curr Opin Lipidol (2016) 0.75
Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed. Sci Rep (2015) 0.75
Contribution of Gut Bacteria to Lipid Levels: Another Metabolic Role for Microbes? Circ Res (2015) 0.75
"The microbiome and immune regulation after transplantation". Transplantation (2016) 0.75
Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial. BMC Gastroenterol (2014) 0.75
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (2010) 12.54
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell (2006) 9.64
Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science (2011) 8.88
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 8.71
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell (2010) 8.69
Human nutrition, the gut microbiome and the immune system. Nature (2011) 7.77
Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev (2001) 7.19
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol (2008) 6.33
Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) (2009) 6.12
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem (2002) 5.53
Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun (2007) 5.06
Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell (2002) 5.01
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem (2003) 4.79
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A (2008) 4.45
Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab (2012) 3.64
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41
Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med (2010) 3.26
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes (2011) 3.06
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology (2005) 2.32
Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr (2005) 2.11
Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology (2008) 1.97
Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A (2011) 1.97
Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab (2010) 1.90
Short-chain fatty acids in germfree mice and rats. J Nutr (1986) 1.84
Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol (2008) 1.75
G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol (2009) 1.65
Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett (2010) 1.65
Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol (1989) 1.50
Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods (2011) 1.47
Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab (2011) 1.43
The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol Cell Biol (2005) 1.35
Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem (2008) 1.31
Evaluation of QIAamp DNA Stool Mini Kit for ecological studies of gut microbiota. J Microbiol Methods (2003) 1.28
SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One (2011) 1.28
Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J Biol Chem (2008) 1.21
Reassessing triglyceride synthesis in adipose tissue. Trends Endocrinol Metab (2008) 1.18
An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev (2002) 1.17
Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes (2011) 1.10
G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX). Toxins (Basel) (2011) 1.08
Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br J Nutr (2012) 1.03
Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Lett (2012) 0.97
p75 neurotrophin receptor regulates glucose homeostasis and insulin sensitivity. Proc Natl Acad Sci U S A (2012) 0.96
Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem Biophys Res Commun (2009) 0.90
Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A1 receptor ligands. Eur J Pharmacol (1994) 0.87
Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways. Br J Pharmacol (2012) 0.87
Colonic energy salvage in chronic pancreatic exocrine insufficiency. JPEN J Parenter Enteral Nutr (2007) 0.85
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell (2008) 10.49
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell (2010) 8.69
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med (2004) 6.16
BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev (2005) 3.97
Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem (2004) 3.94
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell (2005) 3.91
Neuroepithelial progenitors undergo LGN-dependent planar divisions to maintain self-renewability during mammalian neurogenesis. Nat Cell Biol (2007) 3.85
Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells (2005) 3.66
Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. Science (2013) 3.51
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun (2005) 3.38
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation (2004) 3.16
Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer (2009) 3.15
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest (2003) 3.02
Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab (2005) 2.93
JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem (2005) 2.76
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol (2008) 2.73
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell (2007) 2.65
Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol (2003) 2.43
Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol (2009) 2.34
Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med (2009) 2.30
SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab (2009) 2.25
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst (2005) 2.23
PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest (2003) 2.23
GLIDA: GPCR-ligand database for chemical genomic drug discovery. Nucleic Acids Res (2006) 2.21
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics (2010) 2.19
How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol (2009) 2.16
Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J Cell Biol (2011) 2.11
Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology (2003) 2.10
Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet (2004) 2.10
Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One (2009) 2.02
A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol (2008) 2.01
Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci U S A (2006) 1.99
Glycine/Serine polymorphism at position 38 influences KCNE1 subunit's modulatory actions on rapid and slow delayed rectifier K+ currents. Circ J (2014) 1.99
Influence of spinal cord compression and traumatic force on the severity of cervical spinal cord injury associated with ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976) (2014) 1.98
Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol (2003) 1.98
Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A (2011) 1.97
Vesicle endocytosis requires dynamin-dependent GTP hydrolysis at a fast CNS synapse. Science (2005) 1.94
Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation (2005) 1.90
Malat1 is not an essential component of nuclear speckles in mice. RNA (2012) 1.90
The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med (2008) 1.87
The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD). Am J Hum Genet (2004) 1.86
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood (2005) 1.85
Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem (2008) 1.83
Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev (2004) 1.83
Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet (2010) 1.81
Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci (2008) 1.79
Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens (2004) 1.79
Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell (2003) 1.78
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood (2004) 1.78
Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res (2004) 1.77
Diagnosis and treatment of deep pulmonary laceration with intrathoracic hemorrhage from blunt trauma. Ann Thorac Surg (2010) 1.77
Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J (2004) 1.77
Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol Cell Biol (2008) 1.77
CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol (2008) 1.76
MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem (2010) 1.76
Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J (2011) 1.75
Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol (2004) 1.75
Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol (2005) 1.75
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res (2002) 1.75
Neuronal calcium sensor 1 and activity-dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals. Science (2002) 1.75
Remote triggering of deep earthquakes in the 2002 Tonga sequences. Nature (2003) 1.74
Phosphorylation of cytohesin-1 by Fyn is required for initiation of myelination and the extent of myelination during development. Sci Signal (2012) 1.74
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res (2008) 1.73
Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol (2006) 1.72
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet (2011) 1.71
Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J (2003) 1.68
The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. Cancer Sci (2005) 1.67
Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation. Circ J (2012) 1.67
Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res (2006) 1.66
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). Europace (2010) 1.63
Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol (2007) 1.63
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res (2006) 1.61
Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J Biol Chem (2002) 1.61
Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem (2005) 1.60
Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc Natl Acad Sci U S A (2010) 1.60
The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest (2002) 1.60
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J (2008) 1.57
Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.57
Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest (2004) 1.57
Radiation dose rates now and in the future for residents neighboring restricted areas of the Fukushima Daiichi Nuclear Power Plant. Proc Natl Acad Sci U S A (2014) 1.57
CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes (2012) 1.56
Vagal activity modulates spontaneous augmentation of J-wave elevation in patients with idiopathic ventricular fibrillation. Heart Rhythm (2011) 1.56
CRTC3 links catecholamine signalling to energy balance. Nature (2010) 1.55
The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun (2007) 1.55
Establishment of conditional reporter mouse lines at ROSA26 locus for live cell imaging. Genesis (2011) 1.54
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer (2003) 1.54
Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.52
D-dimer level influences thromboembolic events in patients with atrial fibrillation. Int J Cardiol (2005) 1.51
Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett (2002) 1.51
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum (2008) 1.51
MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One (2011) 1.50